Synonymous codon changes can preserve the intended protein sequence while changing the RNA message. Their effects need to be measured in the intended expression system.
Primary experiments showed that synonymous codon choices can affect RNA stability and translation. Work on engineered messenger RNAs also separated codon usage from RNA secondary structure, showing that expression depends on more than a simple codon preference. Optimization is a design objective with a particular assay and system, not a guarantee of improved therapy. Changing codons is distinct from choosing which antigen or epitope the construct encodes.
In four human cell lines, three independent methods showed that mRNA stability tracked codon identity rather than nucleotide content, stabilising codons tended to coincide with higher tRNA levels, and the effect depended on translation (Wu and colleagues, 2019). Another study separated codon usage from coding-region structure in eGFP constructs and defined functional half-life as the time an mRNA is actively translated, which differs from RNA that is merely present or protein that persists, so a doubled reporter signal at one time point does not show twice the RNA lifetime, a better neoantigen or any clinical effect (Mauger and colleagues).
Shares Messenger RNA construct anatomy, Immune measurements and product evidence.
Shares Messenger RNA construct anatomy, Immune measurements and product evidence.
Shares In vitro transcription for RNA products, Immune measurements and product evidence.
Shares Multi-epitope constructs and antigen processing, Immune measurements and product evidence.
Shares In vitro transcription for RNA products, Immune measurements and product evidence.
Shares Multi-epitope constructs and antigen processing, Immune measurements and product evidence.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/